Drugmakers Plot Way Into Obesity Market With Deals and Development : vimarsana.com

Pharmaceutical executives from Amgen to Pfizer are plotting to break into the lucrative obesity market by developing or cutting deals to acquire better drugs that will...

Related Keywords

Germany , Denmark , San Francisco , California , United States , German , Danish , Caroline Humer , Albert Bourla , Novo Nordisk Wegovy , Stefan Oelrich , Zealand Pharma , Marshall Gordon , Patrick Wingrove , Clive Wood , Jay Bradner , David Ricks , Eli Lilly , Boehringer Ingelheim , Pfizer , Novo Nordisk , Reuters , Amgen , Chief Scientific Officer Jay Bradner , Clearbridge Investments , Michael Erman , Bill Berkrot , Obesity , Bese , Biomedical Technology , Iotechnology , Iotech , Obstructive Sleep Apnea , Bstructive Sleep Apnea Syndrome Obstructive Apnoea , Adverse Effects , Ide Effects , Burns , Cardiovascular Disease , Vd Cardiovascular Disease , Children , Hild , Hildhood , Ediatrics , Ids , Drug Development , Rug Discovery , Drug Pipeline , Drug Development Pipeline ,